Feedback Inhibition of Cholesterol Biosynthesis by Dietary Cholesterol in Experimental Chronic Renal Failure
Authors:
- Michal ChmielewskiMCMichal Chmielewski
- Elzbieta Sucajtys-SzulcESElzbieta Sucajtys-Szulc
- Ewa KossowskaEKEwa Kossowska
- Julian SwierczynskiJSJulian Swierczynski
- Boleslaw RutkowskiBRBoleslaw Rutkowski
- Wojciech BoguslawskiWBWojciech Boguslawski
- 1 September 2008
- journal article
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 18 (5) , 448-455
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Additive renoprotective effect of candesartan and tetrahydrobiopterin in rats after 5/6 nephrectomyNephrology Dialysis Transplantation, 2007
- Increased gene expression of liver SREBP-2 in experimental chronic renal failureAtherosclerosis, 2007
- Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequencesAmerican Journal of Physiology-Renal Physiology, 2006
- Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal diseaseJournal of Renal Nutrition, 2003
- Contribution of increased HMG-CoA reductase gene expression to hypercholesterolemia in experimental chronic renal failureMolecular and Cellular Biochemistry, 2003
- Upregulation of acyl-CoA:cholesterol acyltransferase in chronic renal failureAmerican Journal of Physiology-Endocrinology and Metabolism, 2002
- SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liverJournal of Clinical Investigation, 2002
- Diurnal rhythm of cholesterol biosynthesis in experimental chronic renal failureMolecular and Cellular Biochemistry, 2001
- Low Leptin mRNA Level in Adipose Tissue and Normoleptinemia in Experimental Chronic Renal FailureNephron Experimental Nephrology, 2000
- Lipid metabolism and atherosclerosisThe American Journal of Medicine, 1951